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In this report, the role of nitric oxide synthase (NOS) and IL-12 administration in inhibition of vesicular stomatitis virus (VSV)
from infected neuroblastoma cells was examined. We previously have shown that cytokine treatment of cells results in the
induction of NOS-1, and this is associated with a 2 log inhibition of VSV production. We performed these studies to examine
the mechanism by which viral replication is suppressed. Neuroblastoma cells (NB41A3) were treated with either IL-12 or
medium and subsequently infected with VSV. Viral protein and mRNA were isolated from these cells, and their levels were
measured by Western or Northern blots, respectively. mRNA levels were decreased modestly, but viral proteins were
decreased substantially in cells pretreated with IL-12, suggesting that the inhibitory effect of NO is working at the
translational level. Cytokine treatment of cells was not associated with oxidative stress. The viral proteins also were
nitrosylated. These data suggest that the mechanism of NO inhibition of viral replication occurs through translational
interference and posttranslational modifications of viral components. © 1999 Academic Press
Key Words: viral infection; nitric oxide synthase; interleukin-12; innate immunity; acquired immunity.
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sINTRODUCTION
NO has been demonstrated to be a key component in
ost defense against a variety of pathogens including
rotozoan parasites, fungi, bacteria, and viruses (Karu-
iah et al., 1993; Lee et al., 1994; Seguin et al., 1994;
tenger et al., 1994; Harris et al., 1995). It has inhibitory
ffects on ectromelia, vaccinia, and herpes simplex
ype-1 viruses in macrophages (Karupiah et al., 1993) and
he murine Friend leukemia virus (Akarid et al., 1995). It
lso has an inhibitory effect on HIV replication (Mannick
t al., 1996).
Recent studies show that NO, once a suspected car-
inogen associated with environmental pollution, is a
undamental player in physiology (Nathan, 1992; Bredt
nd Snyder, 1994; Nathan and Xie, 1994; Schmidt and
alter, 1994). NO, which is the smallest, simplest mole-
ule known to act as a biological messenger in mam-
als, first was identified as an endothelial cell-relaxing
actor (Furchgott and Zawadzki, 1980; Palmer et al., 1987).
here are three well-characterized isoforms of nitric ox-
de synthase (NOS). All three enzymes have binding
omains for calmodulin, flavin mononucleotide, flavin
denine dinucleotide, NADPH, and a heme-binding site
ear the N terminus.
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334The neuronal isoform (ncNOS, bNOS, NOS-1) is con-
titutively expressed and posttranscriptionally regulated
n neurons of the CNS. It is dependent on calcium and
almodulin, and it exists as a cytosolic homodimer under
ative conditions (Marletta, 1994). The macrophage iso-
orm (NOS-2, iNOS) is rapidly induced by LPS, TNF-a,
nd IFN-g treatment and is calcium independent. NOS-2
s a cytosolic dimer under native conditions (Marletta,
994). In the CNS, it is expressed in astrocytes and
icroglia (Zielasek et al., 1992; Merill et al., 1993; Galea
t al., 1994). The endothelial isoform (NOS-3, ecNOS), is
I linked, membrane associated, and constitutively ex-
ressed but posttranslationally regulated. Like NOS-1, it
s dependent on calcium and calmodulin. It is expressed
n a subset of neurons and endothelial cells (Dawson
nd Dawson, 1994) and astrocytes synthesize NOS-3
Barna et al., 1996), and we recently have shown the
pendymal cells express NOS-3 (Komatsu et al., 1999b).
Interleukin-12 (IL-12) is a heterodimeric cytokine with
5- and 40-kDa subunits (Wolf et al., 1991; Schoenhaut et
l., 1992). It has been shown to mediate a broad range of
ffects on both innate and acquired immunity. It induces
FN-g production, regulates T cell proliferation, stimu-
ates NK cell activity, and enhances CD81 CTL re-
ponses (Kobayashi et al., 1989; Chan et al., 1991; Che-
imi et al., 1993). IL-12 has been shown to induce serum
NF-a levels in LCMV-infected mice (Orange et al., 1994,
995). IL-12 also induces Th1-specific immune re-
ponses and inhibits IL-4 production (Hsieh et al., 1993;
anetti et al., 1993). IL-12 is produced by macrophages,
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335CYTOKINE-MEDIATED INHIBITION OF VSVlymphocytes (Wolf et al., 1994), and by astrocytes
Constantinescu et al., 1996; Stadler et al., 1997).
Viral infections rapidly induce IL-12 gene expression
Coutelier et al., 1995; Ireland et al., 1998). IL-12 has been
n effective therapy in many viral systems (reviewed in
omatsu et al., 1998). Previously we have shown that
L-12 promotes enhanced recovery from VSV infection of
he CNS (Bi et al., 1995; Komatsu and Reiss, 1997). IL-12
reatment of mice is associated with a rise in serum and
NS levels of IFN-g and TNF-a. IL-12 enhanced recovery
lso was seen in IFN-g KO mice, even in the presence of
eutralizing Ab to TNF-a. This strongly suggests that
L-12 directly effected viral clearance and host recovery.
In cytokine- and N-methyl-D-aspartic acid (NMDA)-ac-
ivated but not media-treated NB41A3 cells, we have
hown that suppression of NO production by the NOS-1
pecific inhibitor 7-nitroindazole (7-NI) or the l-arginine
nalogue, L-N-methyl-arginine (L-NMA), eliminates inhi-
ition of VSV replication. In cytokine-activated RAW mu-
ine macrophage cells, however, L-NMA, but not 7-NI,
revents NO-mediated inhibition of VSV replication (Ko-
atsu et al., 1996). In addition, these results have been
xtended in vivo. Administration of 7-NI to VSV-infected
ice resulted in a 10-fold increase in viral titers and brain
omogenates and abrogated the recovery-enhancing ef-
ects of IL-12 treatment (Komatsu et al., 1996). In studies
sing NOS-1 knockout (NOS-1-KO) mice, we have dem-
nstrated a requirement for NO activity in viral clearance.
ompared with wild-type controls, mortality and VSV
iters in brain homogenates of NOS-1-KO mice were
FIG. 1. VSV mRNA transcription is reduced in cells treated with IL-1
2 h before 1 h infection with VSV at m.o.i. of 1. Cells were lysed and th
erformed for the mRNA encoding the M gene (A). The relative density o
ifference in the relative amounts of viral mRNA between the treated an
, Infected CHO; 8, Uninfected CHO].ncreased significantly; there was not the observed ben- Fficial effect of cytokine treatment in NOS-1-KO mice but
here was in NOS-3-KO hosts (Komatsu et al., 1999a).
We have shown both in vitro (Komatsu et al., 1996) and
n vivo (Komatsu et al., 1999a) that NO is a potent antiviral
or VSV, reducing yields by 2 log10. We carried out this
tudy to determine at which stage of the viral life cycle
O is inhibiting viral replication. NB41A3 cells treated
ith IL-12 produced 80% less viral proteins as well as
0% less mRNA. Viral proteins were found to be nitrosy-
ated, suggesting that NO is working at the translational
nd posttranslational level. Infected cells, independent of
L-12 treatment, exhibited oxidative stress.
RESULTS
iral mRNA production
We investigated whether viral mRNA synthesis in
B41A3 cells could be inhibited by IL-12-induced cellular
lterations. NB41A3 cells were incubated with or without
L-12 for 72 h before infection. Analysis of vRNA synthe-
is revealed that IL-12 treatment inhibited VSV mRNA
ranscription (Figs. 1A and 1B). As expected, there was a
adder of transcripts because the RNA-dependent RNA
olymerase complex falls of the vRNA between viral
roteins (Wagner and Rose, 1996). Analysis of the data
eproducibly revealed an ;20% difference in the relative
mounts of viral mRNA between the cytokine treated and
ntreated samples. Thus viral transcription is only mod-
stly inhibited by cytokine-treatment of host cells. These
esults were consistent with the observations shown in
ures of NB41A3 cells were stimulated with media or 5 ng of IL-12 for
A were run on 2% agarose/formaldehyde gel, and a Northern blot was
nds from (A) was measured. The data reveal that there is an ;20–30%
ated samples (B). [(A): lanes 1–3, Unstim. NB41A3; 4–6, Stim. NB41A3;2. Cult
e mRN
f the ba
d untreigs. 2A and 2B.
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336 KOMATSU ET AL.iral protein production
We investigated whether viral protein synthesis in
B41A3 cells was inhibited by IL-12-induced host cell
odifications. NB41A3 cells were treated for 72 h with or
ithout IL-12 before infection. All cells were infected
hen examined by immunohistochemical staining for
SV antigens (data not shown). Western blot analysis of
ell lysates showed that IL-12 treatment significantly
nhibited VSV protein synthesis (Figs. 2A and 2B). Quan-
itative analysis of the data revealed an ;80% difference
n the relative amounts of viral protein between the
reated and untreated samples. These results were con-
istent at both 2.5 and 5 h p.i. and were uniform for each
f the five viral proteins. Therefore there was no bias in
he translation of the viral RNA from 393 59 (N3 L). The
SV virion (1 3 103 pfu) control showed protein levels
imilar to those of the untreated samples.
ther cytokines
We examined the ability of other cytokines to elicit
OS-1 activity assayed by production of NO2 in cell
upernatants. Only IL-12, IFN-g, and TNF-a elicited
his response in NB41A3 cells (Komatsu et al., 1998).
ytokines that failed to induce NOS-1 activity included
FN-a, IL-1, IL-2, IL-4, IL-6, IL-10, and TGF-b (data not
FIG. 2. IL-12 treatment inhibits VSV Protein Production and increases
r IL-12 (5 ng) for 72 h before 2.5 or 5 h infection with VSV at m.o.i. of 1
lot was performed with Abs against VSV proteins (A), or the VSV prote
lot was performed using Abs against nitrotyrosine (C). The relative de
ifference in the relative amounts of viral protein between the treated a
f the samples even though samples treated with IL-12 contained much
and 6, Stim., 2.5 h; 7 and 8, Stim., 5 h; 9, VSV Control; (C): lanes 1–8 c
rom top to bottom is: L, N/P, G, and M.hown). oevels of nitrosylation
One consequence of production of NO in cells is the
odification of proteins by NO on tyrosine residues. To
xamine whether the viral proteins from the samples in
igs. 2A and 2B are nitrosylated, the viral proteins were
mmunoprecipitated and a Western blot was performed
sing a-nitrotyrosine mAb. The levels of nitrosylation in
ll of the samples were found to be very similar even
hough the samples treated with cytokines contained
uch less viral protein (Figs. 2C and 2D), indicating an
ncrease in nitrosylation. As in the previous experiment,
he results were consistent at both 2.5 and 5 h p.i. and
ere uniform for each of the five viral proteins. Thus no
iral protein was selectively modified.
In a separate experiment, NB41A3 cells were incu-
ated with IL-12 or medium on culture slides. The cells
ere either infected with VSV or mock infected with
edia, and the slides were stained for nitrotyrosine.
onsistent with the results of the Western blot, there was
tronger staining in cells treated with IL-12 (Fig. 3). In-
ection with VSV seemed to enhance the staining even
urther.
xidative stress
It was possible that IL-12 treatment of cells resulted in
ation of VSV Proteins in vitro. NB41A3 cells were stimulated with media
were lysed and the proteins run on a 7.5% SDS–PAGE, and a Western
re immunopreciptated, resolved on an 7.5% SDS–Page, and a Western
the bands in (A) and (C) were measured. The data revealed an ;80%
eated samples (B). Levels of nitrosylation, however, were similar in all
iral protein (D). [(A): lanes 1 and 2, Unstim., 2.5 h; 3 and 4, Unstim., 5 h;
nd to lanes 1–8 in (A).] For both (A) and (C), the order of VSV proteinsnitrosyl
. Cells
ins we
nsity of
nd untr
less vxidative stress that could inhibit viral replication. There-
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337CYTOKINE-MEDIATED INHIBITION OF VSVore we examined the GSH/GSSG ratio in cytokine-
reated and infected cells (Fig. 4). The results of this
xperiment are consistent with infection, and not IL-12
reatment, altering the oxidative state of the cell. There-
ore it is unlikely that IL-12 treatment inhibited viral rep-
ication by producing oxidative stress.
DISCUSSION
These studies demonstrate that IL-12 inhibits VSV rep-
ication through suppression of viral RNA synthesis by
0% and viral protein synthesis by 80% (Figs. 1 and 2). A
ubstantial fraction of the viral structural proteins was
hown to be nitrosylated; this may impair folding and
rotein–protein interactions, including viral morphogen-
sis (Figs. 2 and 3). This ultimately results in a 99%
uppression of infectious viral progeny (Komatsu et al.,
996). Viral infection but not cytokine treatment resulted
n oxidative stress to host cells (Fig. 4).
VSV is a negative sense RNA virus that first tran-
cribes its genome into mRNAs after uncoating. NO may
FIG. 3. Immunohistochemistry for nitrotyrosine. Cultures NB41A3 cel
ith VSV at m.o.i. of 1. The cells were stained for nitrotyrosine as prev
ith IL-12. (A) uninfected cells treated with media (bar 5 15 nm). (B) un
edia (bar 5 15 nm). (D) infected cells treated with IL-12 (bar 5 15 nmchieve its biological effect(s) on viral replication inside mhe cell by covalent and/or oxidative modifications of
arget molecules (Stamler et al., 1992; Stamler, 1994) on
iral or host cell proteins or both. There is accumulating
vidence that NO has an inhibitory effect on a variety of
irus infections (reviewed Reiss and Komatsu, 1998). It is
requently difficult to distinguish whether the inhibitory
ffect of NO is the consequence of the inhibition of
ellular metabolism or of virus replication or both. For
accinia virus, late stages of viral replication, which in-
ludes viral DNA replication and virion maturation, were
nhibited by IFN-g-induced NO (Harris et al., 1995). This
ay be due to the inhibition of ribonucleotide reductase
Kwon et al., 1991; Lepoivre et al., 1991), which is the
ate-limiting enzyme in the DNA synthesis. Thus by in-
ctivating this enzyme, NO may be directly inhibiting viral
NA synthesis.
NO may be influencing several steps in the VSV life
ycle to inhibit viral replication. RNA synthesis was found
o be moderately inhibited, and decreased viral protein
ccumulation was observed. Nitrosylated viral proteins
stimulated with media or 5 ng of IL-12 for 72 h before 2.5 h infection
described (Barna et al., 1996). The levels was greater in cells treated
d cells treated with IL-12 (bar 5 15 nm). (C) infected cells treated withls were
iouslyay be inactive and may be eliminated by host cell
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338 KOMATSU ET AL.roteolytic mechanisms. It is unlikely that this anti-VSV
ffect of NO is due to the direct cytotoxic effect of NO on
nfected cells (Bi and Reiss, 1995; Lin et al., 1997). NO
as been demonstrated to directly (Lancaster and Hibbs,
990; Pellat et al., 1990; Nathan, 1992; Stamler et al.,
992) or indirectly (Granger et al., 1980; Granger and
ehninger, 1982; Johnson et al., 1985; Drapier and Hibbs,
986; Hibbs et al., 1990) inhibit numerous cellular en-
ymes. Thus NO may inactivate the viral and host en-
ymes required for viral RNA synthesis and may be
locking viral protein synthesis because the virus can
ot sufficiently amplify viral mRNA.
NO has a single unpaired electron, making it a free
adical. Most eukaryotic cells respond to stress such as
ree radicals by increasing the rate of intracellular pro-
eolysis (Ciechanover and Schwartz, 1994). Thus the IL-
2-treated cells may have increased proteolysis, which
ubsequently results in the degradation of viral proteins
ccumulated in the cells. This may further inhibit viral
NA synthesis by decreasing the availability of RNA-
ependent RNA polymerase or host proteins required for
iral propagation.
The neurons normally do not express MHC class I and
I antigens. Thus the utilization of NO as an antiviral
omponent may be an essential strategy for activated
eurons to retard viral dissemination from infected cells.
he host may rely on NO to clear virus from the CNS
uring the early stages of infection without the cytolytic
ffects of NK and T cells (Bi and Reiss, 1995a; Komatsu
t al., 1996). It has been shown that in some cases, NK
FIG. 4. Concentration of glutathione in NB41A3 cells. NB41A3 cells
ock infected or infected with VSV (m.o.i. of 1). The GSH content was me
f VSV, but IL-12 treatment did not affect the levels. (F, VSV 1 IL-12; Eells can indirectly restrict viral replication without lysis tf the virus-infected cells by stimulating NO production
n macrophages (Karupiah and Harris, 1995). Thus this
ype of inhibitory mechanism may furnish what is lacking
n acquired immunity for virus clearance from neurons in
he CNS (Lin et al., 1997).
Cytokine treatment of NB41A3 results in production of
ore NOS-1, determined by immunohistochemical anal-
sis and by immunoprecipitating NOS-1 (Komatsu et al.,
996). Little is known about the mechanism(s) of IL-12
egulation of type I NOS at present. The sequence of the
romoter of the murine NOS-1 gene has not yet been
ublished. It is possible that IL-12 increases NOS gene
xpression at the transcriptional level or IL-12 increases
he quantity of NOS posttranscriptionally by either in-
reasing the half-life of NOS mRNA or stabilizing the
OS protein. IFN regulatory factor (IRF)-1 is required in
NOS induction in mouse macrophage (Kamijo et al.,
994). Cytokine signal transduction in neurons, however,
ay or may not be similar to that in other types of cells.
wo closely linked, but separable, promoters of human
ype I NOS have been identified (Xie et al., 1995). Our
nalysis of the sequence of the promoter region of hu-
an type I NOS has suggested a STAT core element and
ossible sites for PIE and GAS. IRS, IRF-1, IFN-g-respon-
ive sequence and interferon stimulation responsive el-
ments were not found (Komatsu et al., 1996). There may
e other response elements in the 59 region of the gene,
nd only future investigations and isolation of the murine
romoter(s) will provide the insights necessary. We are
ctively investigating the IL-12 receptor and its signal
5) were cultured with or without IL-12 for 48 h, after which they were
at various time points. The levels of GSH increased with the presence
, IL-12; , untreated).(1 3 10ransduction pathway(s) in neurons.
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339CYTOKINE-MEDIATED INHIBITION OF VSVStudies have shown that intracellular glutathione
GSH) levels in antigen presenting cells influence the
h1/Th2 cytokine response patterns (Peterson et al.,
998). GSH, like NO, is a small molecule that plays key
oles in basic metabolic and cell cycle-related pro-
esses. Among its many functions, this cysteine-contain-
ng tripeptide reduces protein disulfides, detoxifies free
adicals and exogenous toxins, and preserves intracel-
ular redox balances (Garcia-Ruiz et al., 1994; Meissner
t al., 1994).
These cytokines may induce antiviral effects in neu-
ons by activating NOS activity, leading to reduction of
iral RNA and protein while increasing nitrosylation and
mpaired protein interactions. This leads to a reduction in
ields of virus.
MATERIALS AND METHODS
irus
VSV Indiana serotype, San Juan strain, was propa-
ated in Chinese hamster ovary cells and purified using
sucrose gradient. Viral titers were determined on
onolayers of Chinese hamster ovary cells as previously
escribed (Huneycutt et al., 1993).
ytokine treatment of cells
NB41A3 and ATCC cells (5 3 104) were incubated for
2 h at 37°C/5% CO2 on four-well chamber slides with 5
g/ml recombinant murine IL-12 (generously provided by
enetics Institute) or medium. The cells then were in-
ected with VSV at an m.o.i. of 1 or mock infected with
edia. The slides were processed for immunohisto-
hemical staining as previously described (Barna et al.,
996).
In another series of experiments, NB41A3 cells were
reated with 5–10 ng/ml of TNF-a, IFN-g, IFN-a, IL-1, IL-2,
L-4, IL-6, IL-10, or TGF-b (R&D Systems, MN) and the
oncentration of NO2
2, the stable end-product of NO,
as measured (Bredt and Snyder, 1989).
mmunoprecipitation and Immunoblotting
NB41A3 cells (5 3 105) were cultured in medium with
r without IL-12 (5 ng) for 72 h. Cells were mock infected
ith media or infected with VSV (m.o.i. of 1) for 2.5 or 5 h.
ells then were chilled on ice for 10 min and lysed with
.5 ml of lysis buffer (0.5% NP-40, 300 mM NaCl, 50 mM
ris, 100 mg/ml PMSF, and 1 mg/ml leupeptin, pH 7.4) for
0 min. Cell lysates were centrifuged at 12,000 g for 2
in. Equal amounts of supernatant (150 ml) were pre-
leared with 50% protein A-Sepharose two to three times.
heep anti-VSV Ab was added to the cell lysate for 1 h at
7°C. Protein A complex was pelleted in a microfuge for
min and boiled for 5 min in dissociation buffer (0.05%
romphenol blue, 0.0625 M Tris, 1% SDS, 10% glycerol,
% 2-mercaptoethanol) before running on a 7.5% SDS– CAGE gel along with a molecular weight marker (BioRad)
nd electrophoretically transferred onto a nitrocellulose
embrane. After transfer, the blot was washed in PBS-
.05% Tween 20 for 10 min. The blot was blocked using
BS containing 3% nonfat dry milk for 20 min. Anti-VSV
b (1:5000) or anti-nitrotyrosine Ab (Upstate Biotechnol-
gy, NY) (1:10000) was added and the incubation was
arried out at room temperature for 2 h. After washing
he membrane with PBS, HRP-conjugated secondary an-
ibody (anti-sheep for VSV, anti-rabbit for nitrotyrosine;
ector, CA) at 1:3000 dilution for 1.5 h at room tempera-
ure. The blot was incubated with Enhanced Chemilumi-
esence substrate (ECL) (Amersham) using the manu-
acturer’s protocol. A 2-min exposure was used on Kodak
io-Max MR film. Phosphorimaging analysis of the gel
as performed using a Bio-Rad Model GS-250 Molecular
mager.
In a separate experiment, the membranes were simul-
aneously stained for both VSV Ags and nitrosylation.
CR-Dig labeling of the probes
The plasmids encoding the five VSV proteins were
enerously provided by Dr. John Rose (Yale University)
Lawson et al., 1995). These clones were used to gener-
te the probes for the Northern blots.
The PCR Dig Probe Synthesis Reaction (Boehringer
annheim) was used to label the fragments. Briefly, this
equired two sets of PCR reactions. The first reaction
enerates a concentrated batch of double-stranded DNA
ncoding the region of interest. The second reaction
enerates single stranded (either 59 or 39) Dig-labeled
NA probes. The reaction conditions are: Round 1, 103
uffer (5.0 ml), 15 mM MgCl2 (5.0 ml), 59 primer (1.5 mM;
.0 ml), 39 primer (1.5 mM; 5.0 ml), Taq (5 U/ml; 2.5 ml),
NTPs (5.0 ml), DNA (0.1 pg/ml; 10.0 ml), and dH2O (12.5
l).
Round 2 (Vials from Kit), Vial 3 (5.0 ml), Vial 2 (5.0 ml),
rimer (1.5 mM; 10.0 ml), Vial 1 (0.75 ml), DNA (0.1 pg/ml)
1.5–2 ml (;50 ng), dH2O to 50 ml final volume. Both
ounds used the following PCR program: (1) 94°C for 2
in, (2) 55 cycles of 94°C for 30 s, 55°C for 30 s, and
2°C for 90 s, and (3) 15°C hold.
The following primers were used for the PCR reactions:
SV-N gene (base pairs 77–1136): 59-GAGGATCCAGTG-
AATACCCGGC, 39-CTACACCAGCTTACCGAGCCTACC;
SV-P gene (base pairs 47–759): 59-TCCTATTCTCGTCTA-
ATCAGGCG, 39-TATTTCTCCGGTAGGACGAG CCAG;
SV-M gene (base pairs 94–798): 59-AGAAATTAGGGATCG-
AC CACCCC, 39-CAGAGAGGATTAAGGTCGGAGAGC;
SV-G gene (base pairs 211–1400): 59-TGCCCAAGAGTCA-
AAGGCTATTCA, 39-GGTTAGCTGAAAC AGCTTCCAACC;
SV-L gene (base pairs 377–1399): 59-TGTAAACTGCACC
CCTCTGGAAC, 39-GGGCTGAATGATCTGGGTAGCTAT;
ub-actin (base pairs 762–1837): 59-GCCACTGCCGCATC-
TCTTCCTCC, 39-TTGAGGTGT TGAGGCAGCCAGGGC.
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340 KOMATSU ET AL.orthern blot
NB41A3 cells (5 3 105) were cultured in culture me-
ium with or without IL-12 for 72 h. The cells then were
nfected with VSV or mock infected with medium for 1 h,
fter which they were lysed using the Poly(A)pure mRNA
urification kit (Ambion). The mRNA were run on 2%
ormaldehyde/agarose gel and transferred onto a nylon
embrane. After transfer, the membrane was cross-
inked using a UV Crosslinker (Stratagene). The mem-
rane then was incubated in prehybridization buffer for
h at 42°C and hybridized overnight with the probes at
he same temperature.
After the stringency washes, signals were detected
sing the Genius 7 Kit (Boehringer Mannheim). Briefly,
he membrane was incubated in blocking solution for 30
in. The membrane then was incubated with anti-dig/
lkaline phosphatase-conjugated antibody solution for
0 min. After the washes, the membrane was incubated
ith CSPD, which reacts with the alkaline phosphatase
nd exposed on Kodak Bio-Max MR film.
easurement of glutathione levels
NB41A3 cells (1 3 105) were cultured in culture me-
ium with or without IL-12 for 48 h. Cells were mock
nfected with media or with VSV (m.o.i. of 1) for various
ime points. The contents were lysed from the cells with
0% sulfosalicylic acid diluted in PBS, then 50% trietha-
olamine was added to the lysate. The GSH levels were
ssayed by adding 1.5 mM 5,50-dithiobis-2-nitrobenzoic
cid, 0.6 mg/ml NADPH, 8.3 U/ml GSH reductase. The
eaction produces a yellow color, which was quantitated
t OD 405 nm.
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